Any way you look at it, Northwell Health, New York’s largest health system, took a massive hit from COVID-19.
“It just dawned upon us, ‘Hey, we know how to block inflammation,’” recalls Louis Staudt, chief of NCI’s Lymphoid Malignancies Branch and director of the Center for Cancer Genomics.
If you look at attendance, COVID-19 didn’t derail ASCO20.
In a first nationwide study of its kind, two researchers at Memorial Sloan Kettering Cancer Center, Anna Lee and Fumiko Chino, set out to answer two questions:
As a freshly-minted director of H. Lee Moffitt Cancer Center & Research Institute, John Cleveland has two items on top of his to-do list: Rework the center’s leadership, and deal with a crippling pandemic.
The first COVID-19 patient walked into a Mount Sinai ER on March 1.
Programs designed to meet the NCI Community Outreach and Engagement requirements for cancer center designation have positioned the University of Miami Sylvester Comprehensive Cancer Center to monitor the prevalence of SARS-CoV-2 in South Florida.
Nancy Davidson is now in the eleventh week of managing the COVID-19 pandemic—the longest stretch experienced by any health executive in the U.S.
As the District of Columbia, Maryland, and Virginia prepare to loosen pandemic restrictions and reopen economies, hospital networks and academic cancer centers brace for a potential uptick in SARS-CoV-2 infections.
Nobody knew how to even begin to predict the number of people who would register for the first-ever virtual annual meeting of the American Association for Cancer Research.
